Biography:
Brett King specializes in cutaneous immune mediated inflammatory diseases and hair loss disorders. He pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis as well as other conditions. He was the Principal Investigator in the clinical trials leading to approval of Olumiant, Litfulo and Leqselvi for treatment of alopecia areata. He has advanced the use of oral minoxidil for treatment of alopecia areata and androgenetic alopecia.
Dr. King was named an American Academy of Dermatology (AAD) “Patient Care Hero” for his work treating patients with alopecia areata.
Title : Efficacy of deuruxolitinib in patients with severe alopecia areata by baseline alopecia areata episode duration: Pooled analysis of the THRIVE-AA1 and THRIVE-AA2 phase 3 trials